Immuneering Corporation

Q4 2023 13F Holders

Symbol
IMRX
CUSIP
45254E107
Type
Equity
Class
CLASS A COM
Num filings
56
Total reported value, excl. options
$122 M
Manager Report Date Value ($000) Shares Option Type